Eli Lilly is returning its development and commercialization rights to Transition Therapeutics’ TT401 after opting not to advance the diabetes candidate into Phase III development. Transition, which ...
After pledging to stop funding coal-powered power plants last year, the ADB is developing a framework to speed up the region’s green transition. In 2021, the Asian Development Bank (ADB) announced it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results